RIPE-KG · Version 1.1.0 · Resource

ripekg:work/10.1182%2Fblood-2013-04-490821

https://w3id.org/ripe/ripe-kg/work/10.1182%2Fblood-2013-04-490821
SubjectPredicateObject
ripekg:work/10.1136%2Fbmj-2025-084314Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial http://purl.org/spar/cito/cites ripekg:work/10.1182%2Fblood-2013-04-490821Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity
ripekg:work/10.1182%2Fblood-2013-04-490821Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity prism:doi 10.1182/blood-2013-04-490821
ripekg:work/10.1182%2Fblood-2013-04-490821Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity dcterms:title Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity
ripekg:work/10.1182%2Fblood-2013-04-490821Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity rdf:type node1
ripekg:work/10.1182%2Fblood-2013-04-490821Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity rdf:type http://purl.org/spar/fabio/Work
ripekg:work/10.1182%2Fblood-2013-04-490821Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity rdf:type rdfs:Resource
ripekg:work/10.1182%2Fblood-2013-04-490821Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity rdf:type owl:Thing
ripekg:work/10.1182%2Fblood-2013-04-490821Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity rdf:type prov:Entity
ripekg:work/10.1182%2Fblood-2013-04-490821Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity rdf:type ripe:WorkWork
ripekg:work/10.1182%2Fblood-2013-04-490821Inhibitory FcγRIIb (CD32b) becomes activated by therapeutic mAb in both cis and trans and drives internalization according to antibody specificity owl:sameAs https://semopenalex.org/work/W1986574524